{"id":2654,"date":"2025-12-04T15:43:31","date_gmt":"2025-12-04T20:43:31","guid":{"rendered":"https:\/\/bonescan.ca\/?p=2654"},"modified":"2025-12-05T03:34:08","modified_gmt":"2025-12-05T08:34:08","slug":"rems-vs-dxa-limitations-high-risk","status":"publish","type":"post","link":"https:\/\/bonescan.ca\/fr\/rems-vs-dxa-limitations-high-risk\/","title":{"rendered":"5 DXA examens \u00e9chouent : pourquoi les Canadiens ont besoin de REMS technologie"},"content":{"rendered":"<article>\n<figure><\/figure>\n<p>Depuis des d\u00e9cennies, l'analyse de la radiographie \u00e0 double \u00e9nergie DXA (DRE) est la m\u00e9thode de r\u00e9f\u00e9rence pour diagnostiquer l'ost\u00e9oporose. <strong>Cependant<\/strong>, cette m\u00e9thode est souvent insuffisante ou m\u00eame impossible pour certaines populations de patients. Nous devons donc aller au-del\u00e0 des normes \u00e9tablies. Nous nous concentrons sur des solutions cliniques qui \u00e9liminent les risques et fournissent des donn\u00e9es fiables. Voici cinq groupes sp\u00e9cifiques de patients \u00e0 haut risque qui en ont besoin : <strong>REMS Technologie.<\/strong><\/p>\n<h2 id=\"patient-1-pregnancy\">Patient 1 : Femmes qui planifient une grossesse et n\u00e9cessitent un suivi r\u00e9gulier<\/h2>\n<p>Un DXA scanner utilise des rayonnements ionisants. Par cons\u00e9quent, les m\u00e9decins doivent respecter strictement les r\u00e8gles de s\u00e9curit\u00e9. <strong><em>Ne recommande pas<\/em><\/strong>\u00a0Il s\u2019adresse aux femmes enceintes ou qui envisagent une grossesse dans un avenir proche. Cette lacune dans les soins est grave. Elle touche particuli\u00e8rement les femmes qui pr\u00e9sentent une perte osseuse rapide li\u00e9e \u00e0 la grossesse ou \u00e0 l\u2019allaitement.<\/p>\n<p>L'REMS avantage est \u00e9vident : la technologie est enti\u00e8rement <strong>sans rayonnement<\/strong>. Cela permet aux m\u00e9decins de r\u00e9aliser en toute s\u00e9curit\u00e9 des \u00e9valuations et des contr\u00f4les de la BMD pendant la grossesse ou apr\u00e8s l\u2019accouchement. La m\u00eame technologie non ionisante est valid\u00e9e dans des \u00e9tudes sur <a href=\"https:\/\/bonescan.ca\/fr\/changes-of-the-femoral-bone-mineral-density-from-first-to-third-trimester-of-pregnancy-bone-health-assessment-by-means-of-non%e2%80%91ionizing-rems-technology\/\">Sant\u00e9 osseuse maternelle<\/a>.<\/p>\n<h2 id=\"patient-2-scoliosis\">Patient 2 : Personnes pr\u00e9sentant une scoliose s\u00e9v\u00e8re ou ayant subi une intervention chirurgicale au niveau de la colonne vert\u00e9brale<\/h2>\n<p>Contrairement \u00e0 REMS, la quantification DXA d\u00e9pend fortement de la g\u00e9om\u00e9trie. Les patients pr\u00e9sentant des deformit\u00e9s graves de la colonne vert\u00e9brale ou des implants m\u00e9talliques dans la colonne vert\u00e9brale ne peuvent pas \u00eatre scann\u00e9s avec pr\u00e9cision. En particulier, le m\u00e9tal et la courbure anormale g\u00e9n\u00e8rent des artefacts qui entra\u00eenent des scores BMD artificiellement \u00e9lev\u00e9s. Cela masque souvent une v\u00e9ritable ost\u00e9oporose.<\/p>\n<p>La solution REMS technologique est donc essentielle ici. Elle REMS est largement immune \u00e0 ces artefacts g\u00e9om\u00e9triques. Elle fournit des lectures pr\u00e9cises m\u00eame en pr\u00e9sence de l\u00e9sions graves de la colonne vert\u00e9brale ou d\u2019implantations. Cela permet aux patients \u00e0 haut risque de recevoir un diagnostic fiable. Vous pouvez en savoir plus \u00e0 ce sujet dans notre article sur <a href=\"https:\/\/bonescan.ca\/fr\/lumbar-spine-osteoarthritis-bmd-accuracy\/\">arthrose de la colonne lombaire et DXA incapacit\u00e9<\/a>.<\/p>\n<h2 id=\"patient-3-cancer\">Patient 3 : Survivants du cancer sous traitement hormonal<\/h2>\n<p>De nombreux survivants d'un cancer subissent des traitements modulant les hormones qui entra\u00eenent une perte osseuse importante et rapide. Par exemple, les patients trait\u00e9s pour un cancer du sein ou du prostate doivent subir un suivi r\u00e9gulier de l'indice BMD, parfois annuel, pendant de nombreuses ann\u00e9es.<\/p>\n<h3 id=\"zero-radiation-monitoring\">Le contr\u00f4le de la radioactivit\u00e9 \u00e0 z\u00e9ro est une n\u00e9cessit\u00e9 clinique<\/h3>\n<p>Bien que le risque de radiation li\u00e9 \u00e0 un seul DXA scan soit faible, l\u2019exposition cumulative due \u00e0 un suivi fr\u00e9quent et \u00e0 long terme devient un v\u00e9ritable probl\u00e8me clinique. Cependant, la nature non ionisante de cette radiation fait que les doses annuelles sont inf\u00e9rieures \u00e0 celles des scanners traditionnels. <strong>Technologie REMS<\/strong> \u00e9limine compl\u00e8tement ce risque cumulatif. Cela en fait le choix le plus s\u00fbr \u00e0 long terme pour ce groupe de patients crucial.<\/p>\n<h2 id=\"patient-4-immobile\">Patient 4 : Patients fragiles ou immobiles en soins de longue dur\u00e9e<\/h2>\n<p>DXA Les scanners sont des machines volumineuses et immobiles. Cela pose un probl\u00e8me logistique majeur : il faut avec soin transf\u00e9rer les patients fragiles, immobiles ou tr\u00e8s handicap\u00e9s vers un centre d\u2019imagerie. De plus, le patient doit rester parfaitement immobile pendant 20 \u00e0 30 minutes, ce qui est souvent impossible.<\/p>\n<p>Inversement, la REMS technologie est unique en son genre : nous apportons le dispositif directement au chevet du patient ou dans les \u00e9tablissements de soins de longue dur\u00e9e, ce qui am\u00e9liore consid\u00e9rablement l\u2019accessibilit\u00e9. Cette avantage pratique garantit que les patients les plus vuln\u00e9rables ne soient pas exclus des examens de d\u00e9pistage essentiels. Cette utilit\u00e9 est valid\u00e9e par des \u00e9tudes ax\u00e9es sur <a href=\"https:\/\/bonescan.ca\/fr\/rems-motor-disability\/\">REMS chez les patients pr\u00e9sentant une invalidit\u00e9 motrice grave<\/a>.<\/p>\n<h2 id=\"patient-5-quality\">Patient 5 : Les personnes ayant besoin de donn\u00e9es sur la qualit\u00e9 osseuse (en dehors du T-Score)<\/h2>\n<p>La principale limitation de cette m\u00e9thode DXA est sa mesure : elle ne mesure que la densit\u00e9 min\u00e9rale osseuse (DMO). En revanche, les cliniciens reconnaissent d\u00e9sormais que la qualit\u00e9 osseuse \u2014 l\u2019architecture microscopique du squelette \u2014 est le meilleur indicateur de risque de fracture, ind\u00e9pendamment de la densit\u00e9 osseuse.<\/p>\n<p>Le <strong>Technologie REMS<\/strong> fournit l' <strong>Score de fragilit\u00e9<\/strong>. Ce score \u00e9value les donn\u00e9es qualitatives. Cette compr\u00e9hension plus approfondie permet aux m\u00e9decins de rep\u00e9rer les patients dont la BMD semble \u201c normale \u201d mais dont la structure osseuse est faible. <strong>Au bout du compte<\/strong>, Cela permet d\u2019effectuer une \u00e9valuation v\u00e9ritablement compl\u00e8te du risque de fracture.<\/p>\n<h2 id=\"conclusion-beyond\">Conclusion\u00a0: Pourquoi nous devons aller au-del\u00e0 des DXA <strong>\u201c Gold Standard \u201d<\/strong><\/h2>\n<p>Alors que certaines organisations \u0153uvrent pour sensibiliser le public \u00e0 la sant\u00e9 osseuse en g\u00e9n\u00e9ral, les r\u00e9alit\u00e9s cliniques pour les patients \u00e0 risque n\u00e9cessitent une technologie sup\u00e9rieure, sans rayonnements. Les limitations de ce syst\u00e8me, notamment les risques, DXA l\u2019impr\u00e9cision et l\u2019immobilit\u00e9, sont les suivantes : <strong>R\u00e9solu gr\u00e2ce \u00e0 l'innovation REMS technologique<\/strong>.<\/p>\n<p>Prenez le contr\u00f4le de votre sant\u00e9 osseuse gr\u00e2ce au diagnostic le plus avanc\u00e9 et sans rayonnements disponible au Canada. Pour plus d'informations sur le risque d'ost\u00e9oporose et les directives g\u00e9n\u00e9rales, veuillez consulter <a href=\"https:\/\/www.osteoporosis.ca\/\" target=\"_blank\" rel=\"noopener\">Ost\u00e9oporose Canada<\/a>.<\/p>\n<p><a style=\"text-decoration: none; font-weight: bold; font-size: 1.2em; color: #82004b;\" href=\"https:\/\/bonescan.ca\/fr\/contactez-nous-pour-reserver-un-examen-de-densite-osseuse-rems\/\">PLANIFIEZ D\u00c8S MAINTENANT VOTRE EXAMEN DE DENSIT\u00c9 OSSEUSE REMS !<\/a><\/p>\n<\/article>","protected":false},"excerpt":{"rendered":"<p>For decades, DXA (Dual-Energy X-ray Absorptiometry) has been the established method for diagnosing osteoporosis. However, this method is often insufficient or even outright impossible for certain patient populations. Therefore, we must look beyond the standard. We focus on clinical solutions that eliminate risk and deliver reliable data. Here are five specific groups of high-risk patients [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":2655,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[10],"tags":[],"class_list":["post-2654","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pregnancy-and-osteoporosis"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>5 Patients DXA Scans Fail: Why Canadians Need REMS Technology | Advanced Bone Health<\/title>\n<meta name=\"description\" content=\"DXA is the standard, but it fails high-risk patients. Learn 5 cases where REMS Technology vs DXA Limitations makes REMS the necessary choice.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bonescan.ca\/fr\/rems-vs-dxa-limitations-high-risk\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"5 Patients DXA Scans Fail: Why Canadians Need REMS Technology | Advanced Bone Health\" \/>\n<meta property=\"og:description\" content=\"DXA is the standard, but it fails high-risk patients. Learn 5 cases where REMS Technology vs DXA Limitations makes REMS the necessary choice.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bonescan.ca\/fr\/rems-vs-dxa-limitations-high-risk\/\" \/>\n<meta property=\"og:site_name\" content=\"Advanced Bone Health\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Advancedbonehealth\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-04T20:43:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-05T08:34:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bonescan.ca\/wp-content\/uploads\/2025\/12\/The-Hidden-Epidemic-Osteoporosis-in-Canadians-Over-50-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Marketing ABHS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ABHS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cinq patients\u00a0: \u00e9chec du DEXA\u00a0: pourquoi les Canadiens ont besoin de la technologie REMS | Advanced Bone Health","description":"DXA C\u2019est la norme, mais il ne convient pas aux patients \u00e0 haut risque. D\u00e9couvrez 5 cas o\u00f9 la REMS technologie face aux DXA limitations permet REMS de faire le choix n\u00e9cessaire.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bonescan.ca\/fr\/rems-vs-dxa-limitations-high-risk\/","og_locale":"fr_CA","og_type":"article","og_title":"5 Patients DXA Scans Fail: Why Canadians Need REMS Technology | Advanced Bone Health","og_description":"DXA is the standard, but it fails high-risk patients. Learn 5 cases where REMS Technology vs DXA Limitations makes REMS the necessary choice.","og_url":"https:\/\/bonescan.ca\/fr\/rems-vs-dxa-limitations-high-risk\/","og_site_name":"Advanced Bone Health","article_publisher":"https:\/\/www.facebook.com\/Advancedbonehealth","article_published_time":"2025-12-04T20:43:31+00:00","article_modified_time":"2025-12-05T08:34:08+00:00","og_image":[{"width":2000,"height":600,"url":"https:\/\/bonescan.ca\/wp-content\/uploads\/2025\/12\/The-Hidden-Epidemic-Osteoporosis-in-Canadians-Over-50-2.png","type":"image\/png"}],"author":"Marketing ABHS","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Marketing ABHS","Estimation du temps de lecture":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/#article","isPartOf":{"@id":"https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/"},"author":{"name":"Marketing ABHS","@id":"https:\/\/bonescan.ca\/#\/schema\/person\/1c824ae1eaac4b8179b2680b4d6e6702"},"headline":"5 Patients DXA Scans Fail: Why Canadians Need REMS Technology","datePublished":"2025-12-04T20:43:31+00:00","dateModified":"2025-12-05T08:34:08+00:00","mainEntityOfPage":{"@id":"https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/"},"wordCount":623,"commentCount":0,"publisher":{"@id":"https:\/\/bonescan.ca\/#organization"},"image":{"@id":"https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/#primaryimage"},"thumbnailUrl":"https:\/\/bonescan.ca\/wp-content\/uploads\/2025\/12\/The-Hidden-Epidemic-Osteoporosis-in-Canadians-Over-50-2.png","articleSection":["Pregnancy and Osteoporosis"],"inLanguage":"fr-CA","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/","url":"https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/","name":"Cinq patients\u00a0: \u00e9chec du DEXA\u00a0: pourquoi les Canadiens ont besoin de la technologie REMS | Advanced Bone Health","isPartOf":{"@id":"https:\/\/bonescan.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/#primaryimage"},"image":{"@id":"https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/#primaryimage"},"thumbnailUrl":"https:\/\/bonescan.ca\/wp-content\/uploads\/2025\/12\/The-Hidden-Epidemic-Osteoporosis-in-Canadians-Over-50-2.png","datePublished":"2025-12-04T20:43:31+00:00","dateModified":"2025-12-05T08:34:08+00:00","description":"DXA C\u2019est la norme, mais il ne convient pas aux patients \u00e0 haut risque. D\u00e9couvrez 5 cas o\u00f9 la REMS technologie face aux DXA limitations permet REMS de faire le choix n\u00e9cessaire.","breadcrumb":{"@id":"https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/#primaryimage","url":"https:\/\/bonescan.ca\/wp-content\/uploads\/2025\/12\/The-Hidden-Epidemic-Osteoporosis-in-Canadians-Over-50-2.png","contentUrl":"https:\/\/bonescan.ca\/wp-content\/uploads\/2025\/12\/The-Hidden-Epidemic-Osteoporosis-in-Canadians-Over-50-2.png","width":2000,"height":600,"caption":"Bone Density Scan REMS vs Dexa in Pregnancy"},{"@type":"BreadcrumbList","@id":"https:\/\/bonescan.ca\/rems-vs-dxa-limitations-high-risk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bonescan.ca\/"},{"@type":"ListItem","position":2,"name":"5 Patients DXA Scans Fail: Why Canadians Need REMS Technology"}]},{"@type":"WebSite","@id":"https:\/\/bonescan.ca\/#website","url":"https:\/\/bonescan.ca\/","name":"Advanced Bone Health","description":"Service de densitom\u00e9trie osseuse","publisher":{"@id":"https:\/\/bonescan.ca\/#organization"},"alternateName":"Bonescan","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bonescan.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/bonescan.ca\/#organization","name":"Advanced Bone Health","alternateName":"Bonescan","url":"https:\/\/bonescan.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/bonescan.ca\/#\/schema\/logo\/image\/","url":"https:\/\/bonescan.ca\/wp-content\/uploads\/2025\/02\/favicon.png","contentUrl":"https:\/\/bonescan.ca\/wp-content\/uploads\/2025\/02\/favicon.png","width":606,"height":820,"caption":"Advanced Bone Health"},"image":{"@id":"https:\/\/bonescan.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Advancedbonehealth","https:\/\/www.instagram.com\/advanced_bone_health\/"]},{"@type":"Person","@id":"https:\/\/bonescan.ca\/#\/schema\/person\/1c824ae1eaac4b8179b2680b4d6e6702","name":"Marketing ABHS","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/bonescan.ca\/wp-content\/litespeed\/avatar\/67b16f2edbcfe696b7fa21f471f6a56b.jpg?ver=1792613015","url":"https:\/\/bonescan.ca\/wp-content\/litespeed\/avatar\/67b16f2edbcfe696b7fa21f471f6a56b.jpg?ver=1792613015","contentUrl":"https:\/\/bonescan.ca\/wp-content\/litespeed\/avatar\/67b16f2edbcfe696b7fa21f471f6a56b.jpg?ver=1792613015","caption":"Marketing ABHS"},"url":"https:\/\/bonescan.ca\/fr\/author\/awo-moussa\/"}]}},"_links":{"self":[{"href":"https:\/\/bonescan.ca\/fr\/wp-json\/wp\/v2\/posts\/2654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bonescan.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bonescan.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bonescan.ca\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/bonescan.ca\/fr\/wp-json\/wp\/v2\/comments?post=2654"}],"version-history":[{"count":4,"href":"https:\/\/bonescan.ca\/fr\/wp-json\/wp\/v2\/posts\/2654\/revisions"}],"predecessor-version":[{"id":2676,"href":"https:\/\/bonescan.ca\/fr\/wp-json\/wp\/v2\/posts\/2654\/revisions\/2676"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bonescan.ca\/fr\/wp-json\/wp\/v2\/media\/2655"}],"wp:attachment":[{"href":"https:\/\/bonescan.ca\/fr\/wp-json\/wp\/v2\/media?parent=2654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bonescan.ca\/fr\/wp-json\/wp\/v2\/categories?post=2654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bonescan.ca\/fr\/wp-json\/wp\/v2\/tags?post=2654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}